Skip to content

Bruker BRKR Total debt

Total debt at other companies

TEC
Bio-TechneTECH
$290.32M-31.4%
Revvity logo
RevvityRVTY
$3.94B+17.8%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Danaher logo
DanaherDHR
WAT
Waters CorporationWAT
Agilent Technologies logo
Agilent TechnologiesA

Other financials

Income statement

See full
Revenue$823.4M+2.7%
Gross profit$379.8M-2.9%
Operating income$10.2M-67.9%
Net income$14.4M-17.2%
EPS (diluted)$0.02-81.8%

Balance sheet

See full
Cash & equivalents$137.6M-26.7%
Total equity$2.5B+34.6%
Total assets$6.1B+3.3%

Cash flow

See full
Operating cash flow$71.2M+9.5%
CapEx$24.2M-6.9%
Free cash flow$47.0M+20.5%

Valuation

See full
Market cap$8.71B-13.2%
Enterprise value$10.25B-14.9%
P/S2.5×-0.4×

Profitability

See full
Gross margin45.3%-3.7pp
Operating margin1.3%-5.0pp
Net margin-0.6%-10.0pp
FCF margin1.5%-3.6pp

Returns & leverage

See full
Return on equity-1%-21.2pp
Debt / equity0.7×-0.5×
Current ratio1.6×0.0×

Where this comes from

Calculated from Bruker’s reported figures.

The official record: Bruker’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bruker's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bruker's total debt?
Bruker (BRKR) reported total debt of $1.67B in Q1 2026.
How has Bruker's total debt changed year-over-year?
Bruker's total debt decreased by 20.9% year-over-year, from $2.11B to $1.67B.
What is the long-term trend for Bruker's total debt?
Over 5 years (2020 to 2025), Bruker's total debt has grown at a 17.6% compound annual growth rate (CAGR), from $916.2M to $2.06B.
What does total debt mean?
Total debt is the combined amount of all money a company owes to banks, bondholders, and other creditors.
How do you interpret total debt?
An increase in total debt suggests higher financial leverage and potential interest expense pressure, while a decrease indicates deleveraging and improved balance sheet strength.
How does total debt compare across companies?
Peers in the scientific instrumentation and life sciences sector typically maintain debt levels relative to their EBITDA to ensure they can fund R&D and M&A activity without compromising credit ratings.